Yazdan Yazdanpanah to Cohort Studies
This is a "connection" page, showing publications Yazdan Yazdanpanah has written about Cohort Studies.
Connection Strength
0.139
-
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients. J Med Virol. 2021 04; 93(4):2149-2159.
Score: 0.040
-
[Antiretroviral drugs in severe acute respiratory syndrome]. Presse Med. 2006 Jan; 35(1 Pt 2):105-7.
Score: 0.014
-
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity. Nat Immunol. 2021 03; 22(3):322-335.
Score: 0.010
-
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci Transl Med. 2020 09 02; 12(559).
Score: 0.010
-
Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness. Clin Infect Dis. 2018 08 16; 67(5):719-726.
Score: 0.009
-
High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort. J Antimicrob Chemother. 2018 06 01; 73(6):1665-1671.
Score: 0.008
-
The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice. Eur J Gen Pract. 2018 Dec; 24(1):60-67.
Score: 0.008
-
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther. 2017 12; 46(11-12):1054-1060.
Score: 0.008
-
Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients. J Antimicrob Chemother. 2017 10 01; 72(10):2954-2955.
Score: 0.008
-
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. J Antimicrob Chemother. 2017 06 01; 72(6):1745-1751.
Score: 0.008
-
Budget impact of antiretroviral therapy in a French clinic cohort. AIDS. 2017 06 01; 31(9):1271-1279.
Score: 0.008
-
Characteristics and consequences of medical care interruptions in HIV-infected patients in France. Epidemiol Infect. 2016 08; 144(11):2363-70.
Score: 0.007